Physician profile
Michael J Repine
NPI 1316921919
$1,803.54
in general payments reported to CMS, 2019-2025
14 companies · $189 in 2025
The $189 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $42.87 · 2021: $310 · 2022: $228 · 2023: $320 · 2024: $524 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,033.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,033.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,246.46 | 2019-2025 | Mako, Restoration, Triathlon |
| Depuy Synthes Sales INC. | $127.94 | 2023-2024 | Na, Orthovisc, Monovisc |
| Medical Device Business Services, INC. | $117.79 | 2021-2024 | Velys |
| Smith+Nephew, INC. | $78.57 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $69.62 | 2019-2021 | |
| Horizon Therapeutics Plc | $24.70 | 2022 | |
| Averitas Pharma INC. | $23.54 | 2025 | Qutenza |
| Bioventus LLC | $23.11 | 2023 | Gelsyn-3 |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.52 | 2025 | Cabtreo |
| Breg, INC | $15.97 | 2023 | Breg Vpulse, Plasmaflow, Polarcarewave |
| Acumed LLC | $15.89 | 2019 | |
| Avanos Medical | $14.48 | 2019 | |
| Osteomed LLC | $13.85 | 2020 | |
| Zimmer Biomet Holdings, INC. | $12.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Repine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.